In case you missed it: Jan. 17 to Jan. 21

January 21, 2022

Here's what you missed this week from Contemporary OB/GYN®.

Mild to moderate COVID-19 may have no effect on brain of developing fetuses
This week in COVID-19: A patent-free COVID-19 vaccine may be on the horizon
Outcomes of extremely preterm birth
Severity of menopause symptoms can affect cognitive performance

Quality of life in women with deep infiltrating endometriosis and combined oral contraceptives

January 20, 2022

There are a number of effective treatments, but a recent study sought to investigate how well oral contraceptives in particular could help reduce symptoms—while preserving sexual quality of life—in women with particularly severe forms of endometriosis.

Relugolix for treating uterine fibroids

January 19, 2022

A phase 2, multicenter study has found relugolix (Myfembree; Myovant Sciences) significantly decreases menstrual blood loss in women with uterine leiomyomas and is mostly well tolerated.Relugolix is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.

Microbial interplay of recurrent vulvovaginal candidiasis pathobiology

January 19, 2022

A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.